PTPI

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) is a specialty pharmaceutical company founded in 2020 and headquartered in New York, New York. The company went public in December 2020 and focuses exclusively on developing and commercializing therapeutic solutions for men's health conditions. Since its inception, Petros has positioned itself as a niche player in the men's health pharmaceutical market, with particular emphasis on erectile dysfunction treatments and related urological conditions. The company has faced significant financial challenges in recent years, with declining revenues and substantial operating losses affecting its market position.